At the center of discovery and development of cortisol modulation. Our mission is to unlock the potential of cortisol and revolutionize the treatment of serious diseases. For the last 25 years, we’ve led the way in the research and development of selective glucocorticoid receptors (GR) antagonists, molecules that alter GR and regulate cortisol levels. In 2012, we received FDA approval of a groundbreaking cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushing’s syndrome). Today, global partnerships and collaborations form the bedrock of our robust development programs, including more than 500 GR antagonists for conditions spanning oncology, endocrine, and an array of metabolic disorders. What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease. We embrace possibility. We are Corcept.
View Top Employees from Corcept TherapeuticsWebsite | http://www.corcept.com |
Ticker | CORT |
Revenue | $251 million |
Funding | $119 million |
Employees | 371 (345 on RocketReach) |
Founded | 1998 |
Address | 149 Commonwealth Dr, Menlo Park, California 94025, US |
Phone | (650) 327-3270 |
Fax | (650) 327-3218 |
Technologies |
JavaScript,
HTML,
Twitter
+59 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Medical, Health Care, Pharmaceutical |
Web Rank | 3 Million |
Keywords | Psychiatric Treatments, Hormone Replacement Therapy |
Competitors | AGY Therapeutics, Inc., Acadia Pharmaceuticals Inc., Avanir Pharmaceuticals, BIONOMICS LIMITED, OxThera |
SIC | SIC Code 737 Companies, SIC Code 73 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies |
Looking for a particular Corcept Therapeutics employee's phone or email?
The Corcept Therapeutics annual revenue was $251 million in 2024.
Atabak Mokari is the CFO of Corcept Therapeutics.
345 people are employed at Corcept Therapeutics.
Corcept Therapeutics is based in Menlo Park, California.
The NAICS codes for Corcept Therapeutics are [541, 54, 54171, 5417, 541714].
The SIC codes for Corcept Therapeutics are [737, 73].